Gilead Sciences Suffers ‘Sloppy’ Quarter on ‘Unimportant’ Sovaldi Sales
October 29, 2014 at 10:50 AM EDT
Shares of Gilead Sciences (GILD) are falling today after the biotech giant released earnings that the missed the Street consensus. Associated Press Gilead reported a profit of $1.84 a share, missing forecasts for $1.93, on sales of $6.04 billion. Gilead’s earnings were hit by the so-called Branded Prescription Drug Fee, an excise tax included in [...]